News | November 13, 2023
Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
he company posted total income during Q2 FY24 at Rs. 12.86 crore
he company posted total income during Q2 FY24 at Rs. 12.86 crore
This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Investment is additive to KKR’s existing health care growth strategy
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Subscribe To Our Newsletter & Stay Updated
